Mechanism of action of calcium-channel-blocking agents.
暂无分享,去创建一个
[1] E. Antman,et al. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. , 1980, Annals of internal medicine.
[2] P. Lichtlen,et al. Beneficial enhancement of coronary blood flow by nifedipine. Comparison with nitroglycerin and beta blocking agents. , 1981, The American journal of medicine.
[3] Bramahn . Singh,et al. New perspectives in the pharmacologic therapy of cardiac arrhythmias. , 1980, Progress in cardiovascular diseases.
[4] F. Camerini,et al. Haemodynamic effects of nifedipine in heart failure. , 1980, British heart journal.
[5] S. Matsumoto,et al. Hemodynamic effects of nifedipine in congestive heart failure. , 1980, The American journal of cardiology.
[6] A. Fleckenstein. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. , 1977, Annual review of pharmacology and toxicology.
[7] P. Stone,et al. Nifedipine therapy for recurrent ischemic pain following myocardial infarction , 1982, Clinical cardiology.
[8] E. Braunwald,et al. Calcium-channel blockers: pharmacologic considerations. , 1982, American heart journal.
[9] R. Bonow,et al. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. , 1981, The American journal of cardiology.
[10] E. Eisenberg,et al. Regulation and kinetics of the actin-myosin-ATP interaction. , 1980, Annual review of biochemistry.
[11] H. Kambara,et al. Primary pulmonary hypertension: beneficial therapy with diltiazem. , 1981, American heart journal.
[12] R. E. Clark,et al. Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening. , 1979, The American journal of cardiology.
[13] R. Zelis,et al. Calcium blockers : mechanisms of action and clinical applications , 1982 .
[14] D. Harrison,et al. Studies with isolated human coronary arteries. Some general observations, potential mediators of spasm, role of calcium antagonists. , 1980, Chest.
[15] W. Paulus,et al. Modification of Abnormal Left Ventricular Diastolic Properties by Nifedipine in Patients with Hypertrophic Cardiomyopathy , 1982, Circulation.
[16] H. Reuter,et al. A study of the ion selectivity and the kinetic properties of the calcium dependent slow inward current in mammalian cardiac muscle. , 1977, The Journal of physiology.
[17] E. Braunwald,et al. Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[19] B. Lorell,et al. Modification of left ventricular response to pacing tachycardia in nifedipine in patients with coronary artery disease. , 1981, The American journal of medicine.
[20] J. Rouleau,et al. Verapamil Preserves Myocardial Contractility in the Hereditary Cardiomyopathy of the Syrian Hamster , 1982, Circulation research.
[21] P. Caroni,et al. An ATP-dependent Ca2+-pumping system in dog heart sarcolemma , 1980, Nature.
[22] D. Krikler,et al. Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study. , 1979, British heart journal.
[23] W. Barry,et al. Changes in Cellular Na+, K+, and Ca2+ Contents, Monovalent Cation Transport Rate, and Contractile State during Washout of Cardiac Glycosides from Cultured Chick Heart Cells , 1981, Circulation research.
[24] J. Muller,et al. Prevention by Nifedipine of Abnormal Coronary Vasoconstriction in Patients with Coronary Artery Disease , 1981, Circulation.
[25] P. Ludbrook,et al. Laboratory and Initial Clinical Studies of Nifedipine, A Calcium Antagonist for Improved Myocardial Preservation , 1981, Annals of surgery.
[26] B. Vallet,et al. Cyclic adenosine 3',5'-monophosphate-dependent regulation of purified bovine aortic calcium/calmodulin-dependent myosin light chain kinase. , 1981, Biochimica et biophysica acta.
[27] E. Antman,et al. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. , 1980, The New England journal of medicine.
[28] R. Loutzenhiser,et al. Sodium-calcium interactions in mammalian smooth muscle. , 1978, Pharmacological reviews.
[29] E. Braunwald. Coronary artery spasm as a cause of myocardial ischemia. , 1981, The Journal of laboratory and clinical medicine.
[30] S. Vatner,et al. Effects of a Calcium‐channel Antagonist on Large and Small Coronary Arteries in Conscious Dogs , 1982, Circulation.
[31] H. Dargie,et al. Nifedipine and propranolol: a beneficial drug interaction. , 1981, The American journal of medicine.
[32] K. Mcintyre,et al. Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: report of a cooperative clinical trial. , 1982, The American journal of cardiology.
[33] P. Stone,et al. Efficacy of nifedipine therapy for refractory angina pectoris. , 1982, American heart journal.
[34] D. Triggle,et al. Pharmacology of agents that affect calcium. Agonists and antagonists. , 1980, Chest.
[35] R. Chahine,et al. Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina. , 1981, The American journal of medicine.
[36] E. Braunwald,et al. The effect of verapamil on myocardial ultrastructure during and following release of coronary artery occlusion. , 1982, Experimental and molecular pathology (Print).